Search Results for “FDA” – Page 182 – media

Cholesterol Crystals Are Sure Sign A Heart Attack May Loom

A new Michigan State University study on 240 emergency room patients shows just how much of a role a person's cholesterol plays, when in a crystallized state, during a heart attack.
- Source: scienmag
- 528
- November 15, 2017
atherosclerosis cholesterol coronary arteries Researches
US regulators approve first digital pill to track patients

US regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns. The digital pill approved Monday combines two existing products: the former blockbuster psychiatric medication Abilify—long used to treat schizophrenia and bipolar disorder—with a sensor tracking system first approved in 2012.
- Source: medicalxpress
- 502
- November 15, 2017
bipolar disorder blockbuster New Approvals psychiatric schizophrenia
Real-World Study Confirms Lower Brain Bleed Risk with Dabigatran

Real-world outcomes among patients with atrial fibrillation taking the anticoagulant dabigatran (Pradaxa) mimic those reported in clinical trials, with dabigatran use associated with lower rates of brain bleeds, and similar rates of stroke and extracranial hemorrhage as treatment with warfarin in a new study.
- Source: medpagetoday
- 557
- November 14, 2017
atrial fibrillation dabigatran FDA Pradaxa Researches
Robots and AI Will Take Over These 3 Medical Niches First

We’re no stranger to robotics in the medical field. Robot-assisted surgery is becoming more and more common. Many training programs are starting to include robotic and virtual reality scenarios to provide hands-on training for students without putting patients at risk.
- Source: singularityhub
- 499
- November 13, 2017
Artificial Intelligence Market Views robotics surgery
With 2-pronged filing, Novartis’ CAR-T med Kymriah aims to jump intoEurope with both feet

Novartis is blazing ahead with its bid to take its new CAR-T therapy, Kymriah, into new realms with a double-pronged approval application in Europe.
- Source: Fiercepharma
- 509
- November 10, 2017
CAR-T therapy Kymriah Novarti
POLICY CHANGE! Only 35 Days for New Drug Approvals!

Beijing Beishengyan biological Product’s Sabin Strain Inactivated Polioviurs Vaccine (Sabin IPV), secured approval from the China Food and Drug Administration (CFDA) in August 2017. On September 29th, Sabin IPV was officially on the market, offering one more option for IPV precaution. With the exception of time for material supplements, the CFDA took only 35 days to process production, registration and application of Beishengyan’s IPV and issue a drug approval number and certificate.
- Source: Ddu
- 696
- November 10, 2017
Ddu College drug approval IPV vaccine
Cancer cells destroyed in just 3 days with new technique

Cancer cells are relentless, possessing the vexatious ability to develop resistance to current therapies and making the disease hugely challenging to treat. However, an exciting new study may have identified cancer's weak spot; the discovery has already led to the near-eradication of the disease in cell cultures.
- Source: medicalnewstoday
- 670
- November 8, 2017
cancer cell chromatin Researches
Teva looks to sell generics in China through joint venture with Guangzhou Pharma

As the world’s largest generics maker, Teva still doesn’t have much of a presence in China, even though it is a country relies heavily on generics. The Israeli company is looking to remedy that by reportedly forming a joint venture with local company Guangzhou Pharma
- Source: Fiercepharma
- 519
- November 7, 2017
China generics Teva
New tissue-engineered blood vessel replacements one step closer to human trials

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
- Source: worldpharmanews
- 533
- November 7, 2017
biological blood vessel kidney dialysis Researches
Amgen, Novartis Rev Up for New Alzheimer’s Study

Amgen and Basel, Switzerland-based Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute (BAI) to launch a new clinical trial in Alzheimer’s.
- Source: Pharmalive
- 676
- November 6, 2017
Alzheimer's API Clinical Trial Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.